Vascular Pathways is a medical technology company focused on developing and commercialising novel vascular access devices, featuring the company’s proprietary integrated nitinol guidewire technology. The company's comprehensive portfolio of AccuCath™ devices consist of best-in-class, and FDA-cleared, peripheral intravenous (IV) catheters, and address all clinical situations requiring peripheral vascular access. The company’s IV catheters are designed to: (i) increase first attempt success, (ii) extend dwell times, (iii) reduce complication rates, (iv) increase patient satisfaction, and (v) and reduce healthcare costs.
MVM sold the Vascular Pathways Group of Companies (Vascular Pathways, Inc. and Vascular Pathways Europe, Ltd.) to C.R. Bard on July 1, 2015. The transaction provides C.R. Bard with a best-in-class portfolio of peripheral vascular access technologies.
980 Federal Highway, Suite 308
Boca Raton, FL 33432